MML Investors Services’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
FCM
WCMNY
PCM
AAM
MML Investors Services's AMED Position: Q3 2024 in Review
MML Investors Services sold out of Amedisys (AMED) in Q3 2024, closing a stake of 6,610 shares — an estimated $607K sold.
MML Investors Services first reported a position in AMED in Q3 2020 and held it in 14 quarters. The position peaked at $874K in Q1 2022. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.
- MML Investors Services reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
- MML Investors Services sold 6,610 Amedisys shares in Q3 2024, an estimated $607K.
- MML Investors Services first reported a position in Amedisys in Q3 2020 and held it in 14 quarters.
- MML Investors Services's Amedisys position peaked at $874K in Q1 2022.
- 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.
Based on MML Investors Services's 13F filing for Q3 2024, filed 15 Nov 2024.